Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aminoacyltransferases | 2 | 2018 | 67 | 0.830 |
Why?
|
| Cysteine Endopeptidases | 3 | 2021 | 662 | 0.720 |
Why?
|
| Receptors, LDL | 1 | 2021 | 543 | 0.700 |
Why?
|
| Peptidyl Transferases | 1 | 2018 | 57 | 0.700 |
Why?
|
| Erythroid Precursor Cells | 3 | 2017 | 226 | 0.650 |
Why?
|
| Hyperlipidemias | 1 | 2021 | 801 | 0.600 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 4250 | 0.590 |
Why?
|
| Antigen Presentation | 1 | 2022 | 1301 | 0.580 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 830 | 0.560 |
Why?
|
| Peptides | 5 | 2022 | 4434 | 0.560 |
Why?
|
| Erythropoiesis | 2 | 2018 | 707 | 0.500 |
Why?
|
| Down-Regulation | 1 | 2021 | 3091 | 0.490 |
Why?
|
| Immune Tolerance | 2 | 2021 | 2332 | 0.460 |
Why?
|
| Influenza, Human | 1 | 2022 | 1378 | 0.430 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2371 | 0.430 |
Why?
|
| Melanoma, Experimental | 4 | 2021 | 564 | 0.350 |
Why?
|
| Major Histocompatibility Complex | 2 | 2022 | 1023 | 0.340 |
Why?
|
| Erythrocytes | 4 | 2021 | 2421 | 0.320 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 4005 | 0.320 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2022 | 1539 | 0.310 |
Why?
|
| Erythrocyte Membrane | 2 | 2021 | 444 | 0.300 |
Why?
|
| Erythroblasts | 2 | 2018 | 162 | 0.290 |
Why?
|
| Protein Engineering | 2 | 2021 | 556 | 0.290 |
Why?
|
| Antigens | 2 | 2022 | 1511 | 0.290 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2022 | 1425 | 0.270 |
Why?
|
| Immunity, Cellular | 2 | 2021 | 1694 | 0.270 |
Why?
|
| Mice | 19 | 2022 | 80995 | 0.250 |
Why?
|
| Genetic Engineering | 2 | 2021 | 956 | 0.240 |
Why?
|
| Hemagglutinins | 1 | 2022 | 107 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2021 | 3872 | 0.230 |
Why?
|
| Camelids, New World | 1 | 2021 | 20 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3803 | 0.220 |
Why?
|
| Mannans | 1 | 2022 | 69 | 0.220 |
Why?
|
| Pandemics | 1 | 2021 | 7213 | 0.220 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2021 | 34 | 0.210 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2020 | 1030 | 0.210 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 105 | 0.210 |
Why?
|
| Influenza A virus | 2 | 2021 | 453 | 0.210 |
Why?
|
| Histocompatibility | 1 | 2021 | 362 | 0.190 |
Why?
|
| Tumor Microenvironment | 4 | 2020 | 3071 | 0.190 |
Why?
|
| Animals | 22 | 2022 | 170726 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 4 | 2022 | 1831 | 0.190 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 339 | 0.190 |
Why?
|
| Catalysis | 2 | 2018 | 821 | 0.190 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2021 | 240 | 0.180 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 14237 | 0.180 |
Why?
|
| Candida albicans | 1 | 2022 | 364 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 22936 | 0.170 |
Why?
|
| Transduction, Genetic | 1 | 2021 | 966 | 0.170 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2018 | 144 | 0.170 |
Why?
|
| Phosphorylcholine | 1 | 2018 | 167 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 984 | 0.160 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 529 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 583 | 0.160 |
Why?
|
| Antigens, Viral | 1 | 2022 | 1164 | 0.160 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 1180 | 0.150 |
Why?
|
| Autoantigens | 1 | 2021 | 911 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 977 | 0.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1055 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 6677 | 0.140 |
Why?
|
| Dexamethasone | 1 | 2022 | 1949 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 1487 | 0.140 |
Why?
|
| Precancerous Conditions | 1 | 2021 | 940 | 0.140 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2017 | 199 | 0.130 |
Why?
|
| Molecular Imaging | 1 | 2021 | 852 | 0.130 |
Why?
|
| Substrate Specificity | 1 | 2018 | 1900 | 0.130 |
Why?
|
| Immunotherapy | 2 | 2021 | 4118 | 0.130 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 486 | 0.120 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 2986 | 0.120 |
Why?
|
| Reticulocytes | 1 | 2014 | 319 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1847 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 1797 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1652 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4321 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1488 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9923 | 0.110 |
Why?
|
| Gene Deletion | 2 | 2018 | 2832 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2014 | 780 | 0.100 |
Why?
|
| Osteopontin | 1 | 2012 | 352 | 0.100 |
Why?
|
| Inflammation | 3 | 2022 | 10082 | 0.100 |
Why?
|
| Soft Tissue Injuries | 1 | 2012 | 179 | 0.100 |
Why?
|
| Body Weight | 1 | 2021 | 4692 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2021 | 4169 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 6858 | 0.090 |
Why?
|
| Cytokines | 3 | 2021 | 7225 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2021 | 20101 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1398 | 0.090 |
Why?
|
| Species Specificity | 1 | 2014 | 2620 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3687 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4375 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2021 | 6230 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1602 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3050 | 0.080 |
Why?
|
| Humans | 15 | 2022 | 715124 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3450 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5441 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5312 | 0.070 |
Why?
|
| Epitopes | 2 | 2022 | 2654 | 0.070 |
Why?
|
| Erythrocyte Transfusion | 2 | 2021 | 531 | 0.070 |
Why?
|
| Apoptosis | 1 | 2021 | 10112 | 0.070 |
Why?
|
| Melanoma | 1 | 2021 | 5274 | 0.060 |
Why?
|
| Regeneration | 1 | 2012 | 1543 | 0.060 |
Why?
|
| Macrophages | 2 | 2022 | 5805 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2014 | 6137 | 0.060 |
Why?
|
| Transcription Factor RelB | 1 | 2022 | 31 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 3276 | 0.060 |
Why?
|
| Aluminum Hydroxide | 1 | 2022 | 59 | 0.060 |
Why?
|
| Oldenlandia | 1 | 2021 | 3 | 0.060 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 155 | 0.050 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 111 | 0.050 |
Why?
|
| beta-Glucans | 1 | 2022 | 122 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5153 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 486 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2022 | 276 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11746 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5000 | 0.050 |
Why?
|
| Cell Tracking | 1 | 2021 | 147 | 0.050 |
Why?
|
| Pregnancy | 1 | 2021 | 27180 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2021 | 276 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2021 | 282 | 0.050 |
Why?
|
| Solubility | 1 | 2022 | 1163 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2021 | 323 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2022 | 1172 | 0.050 |
Why?
|
| Paranasal Sinuses | 1 | 2022 | 269 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 574 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2021 | 359 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 16943 | 0.040 |
Why?
|
| Granzymes | 1 | 2020 | 280 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 610 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 679 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2022 | 1017 | 0.040 |
Why?
|
| Botulism | 1 | 2017 | 21 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2018 | 224 | 0.040 |
Why?
|
| Whole-Body Irradiation | 1 | 2018 | 456 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 23973 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9521 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 12567 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2018 | 334 | 0.040 |
Why?
|
| Female | 5 | 2021 | 377334 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 536 | 0.040 |
Why?
|
| Immunization | 1 | 2022 | 1277 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18345 | 0.040 |
Why?
|
| Protein Binding | 2 | 2021 | 9661 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1900 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 4980 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 1982 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1923 | 0.040 |
Why?
|
| Dogs | 1 | 2021 | 4047 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 1705 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2018 | 416 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 489 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 420 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 2842 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 971 | 0.030 |
Why?
|
| Retroviridae | 1 | 2017 | 959 | 0.030 |
Why?
|
| Ligands | 1 | 2022 | 3332 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3825 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 1372 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1231 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1381 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 15260 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1785 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 817 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1331 | 0.030 |
Why?
|
| Lung | 2 | 2022 | 9765 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1408 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1949 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2017 | 1588 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 936 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 5535 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2189 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1751 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3694 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2102 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3433 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2022 | 2950 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2018 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6480 | 0.020 |
Why?
|
| Anemia | 1 | 2017 | 1416 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 4918 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2018 | 2474 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 6131 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2017 | 3554 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11766 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3489 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 16680 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3862 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2862 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7836 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10531 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 8010 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3970 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4933 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9584 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10379 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 16011 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 29442 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13732 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18789 | 0.010 |
Why?
|
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_